You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 254 No. 22, December 13, 1985 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (109)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Obesity as a Predictor of Poor Antibody Response to Hepatitis B Plasma Vaccine

David J. Weber, MD, MPH; William A. Rutala, PhD, MPH; Gregory P. Samsa, MS; Jane E. Santimaw, RN; Stanley M. Lemon, MD

JAMA. 1985;254(22):3187-3189.


Abstract

Factors associated with lack of antibody response to the hepatitis B virus plasma vaccine were retrospectively evaluated by means of a logistic regression in 194 previously seronegative staff members of a community hospital. All subjects had received three doses of vaccine by intramuscular buttock injection using a 1-in, 23-gauge needle. Overall, only 55.7% of subjects developed detectable antibody to hepatitis B surface antigen in serum after immunization. The weight-height index served as a surrogate measure of obesity. Predictors of poor immunogenic response to hepatitis B vaccine included higher weight-height index, older age, and vaccine batch. Sex, race, timing of vaccine doses, and timing of postimmunization determination of antibody to hepatitis B surface antigen were not predictors of vaccine efficacy.

(JAMA 1985;254:3187-3189)



Author Affiliations

From the Department of Hospital Epidemiology, North Carolina Memorial Hospital (Drs Weber and Rutala, Mr Samsa, and Ms Santimaw), and the Division of Infectious Disease, Department of Medicine (Drs Weber, Rutala, and Lemon), University of North Carolina at Chapel Hill.


Footnotes

Read before the 25th Interscience Conference on Antimicrobial Agents and Chemotherapy, Minneapolis, Sept 30, 1985.

Reprint requests to Division of Infectious Diseases, University of North Carolina at Chapel Hill, 547 Clinical Sciences Bldg 229H, Chapel Hill, NC 27514 (Dr Weber).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Obesity accelerates thymic aging
Yang et al.
Blood 2009;114:3803-3812.
ABSTRACT | FULL TEXT  

Immunogenicity in humans of an edible vaccine for hepatitis B
Thanavala et al.
Proc. Natl. Acad. Sci. USA 2005;102:3378-3382.
ABSTRACT | FULL TEXT  

Safety and immunoenhancing effect of a Chlorella-derived dietary supplement in healthy adults undergoing influenza vaccination: randomized, double-blind, placebo-controlled trial
Halperin et al.
CMAJ 2003;169:111-117.
ABSTRACT | FULL TEXT  

A Randomized Trial of Alternative Two- and Three-Dose Hepatitis B Vaccination Regimens in Adolescents: Antibody Responses, Safety, and Immunologic Memory
Cassidy et al.
Pediatrics 2001;107:626-631.
ABSTRACT | FULL TEXT  

Use of Licensed Vaccines for Active Immunization of the Immunocompromised Host
Pirofski and Casadevall
Clin. Microbiol. Rev. 1998;11:1-26.
ABSTRACT | FULL TEXT  

Determination of Deltoid Fat Pad Thickness: Implications for Needle Length in Adult Immunization
Poland et al.
JAMA 1997;277:1709-1711.
ABSTRACT  

Vaccines to Prevent Viral Hepatitis
Lemon and Thomas
NEJM 1997;336:196-204.
FULL TEXT  

Immunogenicity of a Recombinant Hepatitis B Vaccine in Adults
Bock et al.
Arch Intern Med 1996;156:2226-2231.
ABSTRACT  

Factors Associated with Hepatitis B Vaccine Response Among Dentists
Cleveland et al.
JDR 1994;73:1029-1035.
ABSTRACT  

Hepatitis B Vaccine Responsiveness in Connecticut Public Safety Personnel
Roome et al.
JAMA 1993;270:2931-2934.
ABSTRACT  

Risk Factors for Lack of Detectable Antibody Following Hepatitis B Vaccination of Minnesota Health Care Workers
Wood et al.
JAMA 1993;270:2935-2939.
ABSTRACT  

Antibody to Human Immunodeficiency Virus (HIV) and Suboptimal Response to Hepatitis B Vaccination
Collier et al.
ANN INTERN MED 1988;109:101-105.
ABSTRACT  

Duration of Immunity After Hepatitis B Vaccination: Efficacy of Low-Dose Booster Vaccine
HOROWITZ et al.
ANN INTERN MED 1988;108:185-189.
ABSTRACT  

Hepatitis B Vaccines--to Switch or Not to Switch
Hollinger
JAMA 1987;257:2634-2636.
ABSTRACT  

Response to Deltoid Muscle Injection of Hepatitis B Vaccine After Failure to Respond to Gluteal Injections
Weber et al.
JAMA 1986;255:2157-2157.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.